Zobrazeno 1 - 10
of 356
pro vyhledávání: '"Francisco, Leyva"'
Autor:
María Herrera de la Muela, MD, PhD, Santiago Sanz Medrano, MD, Francisco Leyva, MD, PhD, Inmaculada Masa Jurado, MD, PhD, Ana I. Membrilla Ortiz, NP, Juana Brenes Sánchez, MD, PhD, Miriam de la Puente Yagüe, MD, PhD, Jorge Ruiz Rodríguez, MD, PhD, Javier Buendía Pérez, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 12, Iss 5, p e5846 (2024)
Background:. The paradigm of healthcare has evolved toward patient-centered approaches, where shared decision-making (SDM) plays a pivotal role. This study aimed to explore the implementation of SDM during breast cancer reconstruction consultations a
Externí odkaz:
https://doaj.org/article/0d6f1c1aa5ba4dd2abfbd671b815c128
Autor:
Daniel Hammersley, MD, Abbasin Zegard, MD, Emmanuel Androulakis, MD, Richard Jones, MD, PhD, Osita Okafor, MD, Suzan Hatipoglu, MD, Lukas Mach, MD, Amrit Lota, MD, PhD, Zohya Khalique, MD, PhD, Antonio De Marvao, MD, PhD, Resham Baruah, MD, PhD, Kaushik Guha, James Ware, PhD, Upasana Tayal, MD, PhD, Dudley Pennell, MD, FSCMR, Brian Halliday, MD, PhD, BSc, Tian Qiu, Sanjay Prasad, MD, PhD, Francisco Leyva, MD, PhD
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss , Pp 100353- (2024)
Externí odkaz:
https://doaj.org/article/795b5b5fcf294715bb7ec9fe9b895462
Autor:
Tamara Naneishvili, Francisco Leyva, Alex Zaphiriou, Peysh A Patel, Tian Qiu, Berthold Stegemann, Abbasin Zegard, Ravi Viyapurapu, Purushottam Desai, Sam White
Publikováno v:
Open Heart, Vol 10, Iss 2 (2023)
Objective To determine the diagnostic yield of a ‘high’ N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with suspected heart failure (HF) referred from primary to secondary care.Methods In this retrospective study, cardiac diagno
Externí odkaz:
https://doaj.org/article/fc9d81c7eaf34daf8af829dd406abc95
Autor:
Ravi Vijapurapu, William Bradlow, Francisco Leyva, James C. Moon, Abbasin Zegard, Nigel Lewis, D. Kotecha, Ana Jovanovic, Derralynn A. Hughes, Peter Woolfson, Richard P. Steeds, Tarekegn Geberhiwot
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-5 (2022)
Abstract Background Fabry disease (FD) is a treatable X-linked condition leading to progressive cardiac disease, arrhythmia and premature death. We aimed to increase awareness of the arrhythmogenicity of Fabry cardiomyopathy, by comparing device usag
Externí odkaz:
https://doaj.org/article/ce55df8f52ed4ee4903f9e5db9f11ce0
Autor:
Manav Sohal, MBBS, Shoaib Hamid, MD, Giovanni Perego, MD, Paolo Della Bella, MD, Shaumik Adhya, MD, John Paisey, MD, Tim Betts, MD, Ravi Kamdar, MD, Pier Lambiase, MD, Francisco Leyva, MD, Janet M. McComb, MD, Jonathan Behar, MD, Thomas Jackson, MD, Simon Claridge, MD, Vishal Mehta, MD, Mark Elliott, MD, Steven Niederer, PhD, Reza Razavi, MD, C. Aldo Rinaldi, MD, FHRS
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 1, Pp 19-27 (2021)
Background: No periprocedural metric has demonstrated improved cardiac resynchronization therapy (CRT) outcomes in a multicenter setting. Objective: We sought to determine if left ventricular (LV) lead placement targeted to the coronary sinus (CS) br
Externí odkaz:
https://doaj.org/article/6d92c1569ac34e2fa9e3c585e2ea24fd
Autor:
Maciej Sterliński, Joanna Zakrzewska-Koperska, Aleksander Maciąg, Adam Sokal, Joaquin Osca-Asensi, Lingwei Wang, Vasiliki Spyropoulou, Baerbel Maus, Francesca Lemme, Osita Okafor, Berthold Stegemann, Richard Cornelussen, Francisco Leyva
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
The aim of the SYNSEQ (Left Ventricular Synchronous vs. Sequential MultiSpot Pacing for CRT) study was to evaluate the acute hemodynamic response (AHR) of simultaneous (3P-MPP syn) or sequential (3P-MPP seq) multi-3-point-left-ventricular (LV) pacing
Externí odkaz:
https://doaj.org/article/84fa3fcd514e40f0989f30f4b2f91fe8
Autor:
Ravi Vijapurapu, Rebecca Kozor, Derralynn A. Hughes, Peter Woolfson, Ana Jovanovic, Patrick Deegan, Rosemary Rusk, Gemma A. Figtree, Michel Tchan, David Whalley, Dipak Kotecha, Francisco Leyva, James Moon, Tarekegn Geberhiwot, Richard P. Steeds
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Fabry disease (FD) is a genetic disorder caused by a deficiency in the enzyme alpha-galactosidase A, leading to an accumulation of glycosphingolipids in tissues across the body. Cardiac disease is the leading cause of morbidity an
Externí odkaz:
https://doaj.org/article/947c021c81ff4e06afdba2426fd912a4
Autor:
Richard E. Jones, Hassan A. Zaidi, Daniel J. Hammersley, Suzan Hatipoglu, Ruth Owen, Gabriel Balaban, Antonio de Marvao, François Simard, Amrit S. Lota, Ciara Mahon, Batool Almogheer, Lukas Mach, Francesca Musella, Xiuyu Chen, John Gregson, Laura Lazzari, Andrew Ravendren, Francisco Leyva, Shihua Zhao, Ali Vazir, Pablo Lamata, Brian P. Halliday, Dudley J. Pennell, Martin J. Bishop, Sanjay K. Prasad
Publikováno v:
JACC: Cardiovascular Imaging. 16:628-638
Background Late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) offers the potential to noninvasively characterize the phenotypic substrate for sudden cardiac death (SCD). Objectives The authors assessed the utility of infarct character
Publikováno v:
Journal of Innovative Optical Health Sciences, Vol 14, Iss 2, Pp 2150001-1-2150001-7 (2021)
The intra-operative real-time assessment of tissue viability can potentially improve therapy delivery and clinical outcome in cardiovascular therapies. Cardiac ablation therapy for the treatment of supraventricular or ventricular arrhythmia continues
Externí odkaz:
https://doaj.org/article/4ea931972dc246129f95b093b3c6ad55
Publikováno v:
Circulation. 147:759-767
The notion that the risk of sudden cardiac death (SCD) in patients with heart failure (HF) is declining seems to be gaining traction. Numerous editorials and commentaries have suggested that SCD, specifically arrhythmic SCD, is no longer a significan